{"ticker": {"uuid": "0aaf3af5-1f47-421a-861d-492b444847cb", "symbol": "STAA", "name": "STAAR Surgical Company", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Instruments & Supplies"}, "articles": [{"title": "Staar Surgical's China ICL Demand Driven by Macro Affordability Pressures, Wedbush Says", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxPbjBNem1pcXQ2UGprT3M5T3JLYkI3eXNobHFnU3JrdFZNWFpSS2RMUEVacmV5VHRZOHptX09sNmtrdXRuckdUUE1MclJ4X2JlMUVrX2hrd0ctX21TaXNGOFAzSGItVTNvMC0xcF95YThOUmhsMGlNWGpDdklSRV92UTFlNzhyYWd3aGl5U2JnRDlmTFFMWTVPSkVFbEp5TWpfRXd1dlZTVjdOaWxzZ0hvb0pUeEZtUnJ4VEtoZlFZUEdfWThDTGtBcWhRc0JIZWVmX3EwVEhR?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-15T14:54:16+00:00", "published_display": "15 Jul 2026 14:54", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Trading Systems Reacting to (STAA) Volatility", "summary": "Staar Surgical Company (NASDAQ: STAA) is exhibiting weak near and mid-term sentiment, potentially pressuring a neutral long-term outlook. AI models have generated three distinct trading strategies\u2014Position Trading, Momentum Breakout, and Risk Hedging\u2014to capitalize on a mid-channe", "url": "https://news.stocktradersdaily.com/news_release/90/Trading_Systems_Reacting_to_STAA_Volatility_071026043602_1783672562.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-10T04:10:31", "published_display": "10 Jul 2026 04:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAA Stock On Track For Its Fourth Straight Session Of Gains \u2013 This Analyst Would Rather Be Early Than Late On Staar\u2019s Growth Story", "summary": "Shares of Staar Surgical (STAA) rose over 10% after strong first-quarter results led multiple analysts to issue bullish ratings. Wedbush upgraded STAA to 'Outperform' with a $40 price target, citing a potential full China rebound and long-term growth exceeding expectations. Canac", "url": "https://stocktwits.com/news-articles/markets/equity/staa-stock-on-track-for-its-fourth-straight-session-of-gains-earnings-analysts-upgrade-stock/cZX1wjjReSd", "source_name": "Stocktwits", "published_at": "2026-07-09T16:10:31", "published_display": "09 Jul 2026 16:10", "sentiment": "positive", "sentiment_pct": 86, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Heidelberg Engineering, STAAR, Ziemer to showcase latest technologies at ESCRS 2025", "summary": "Heidelberg Engineering, STAAR Surgical, and Ziemer Ophthalmic Systems are set to present their latest advancements in cataract and refractive surgery at the 43rd ESCRS Congress in Copenhagen. Heidelberg Engineering will launch a new ANTERION software update with improved cataract", "url": "https://www.ophthalmologytimes.com/view/heidelberg-staar-ziemer-showcase-latest-technologies-cataract-refractive-escrs-2025", "source_name": "Ophthalmology Times", "published_at": "2026-07-08T01:09:30", "published_display": "08 Jul 2026 01:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAAR Surgical Co highlights its vision correction technology as investors weigh long-term growth", "summary": "STAAR Surgical Co (ISIN US8577001096) specializes in implantable collamer lenses for refractive vision correction, positioning itself in the growing market for advanced eye surgery. The company's business model focuses on supplying high-value medical devices to eye care professio", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/staar-surgical-co-highlights-its-vision-correction-technology-as-investors/69714273", "source_name": "AD HOC NEWS", "published_at": "2026-07-07T14:47:00", "published_display": "07 Jul 2026 14:47", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "3 Reasons to Avoid STAA and 1 Stock to Buy Instead", "summary": "This article recommends avoiding STAAR Surgical (STAA) despite its recent stock gains, citing three main reasons: declining revenue, a dropping free cash flow margin, and a decrease in Return on Invested Capital (ROIC). The author suggests better investment opportunities exist an", "url": "https://stockstory.org/us/stocks/nasdaq/staa/news/buy-or-sell/3-reasons-to-avoid-staa-and-1-stock-to-buy-instead-5", "source_name": "StockStory", "published_at": "2026-07-02T19:09:51", "published_display": "02 Jul 2026 19:09", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Staar Surgical Company (STAA) Affects Rotational Strategy Timing", "summary": "This article analyzes Staar Surgical Company (STAA) through an AI model, revealing strong near-term sentiment but neutral mid and long-term outlooks. It highlights a significant short setup with a 67.7:1 risk-reward ratio targeting a 19.2% downside. The analysis provides three in", "url": "https://news.stocktradersdaily.com/news_release/98/How_Staar_Surgical_Company_STAA_Affects_Rotational_Strategy_Timing_062926032802_1782718082.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-29T03:28:00", "published_display": "29 Jun 2026 03:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAAR Surgical Company Actuals & Estimates (NASDAQ:STAA)", "summary": "This article provides an overview of STAAR Surgical Company (NASDAQ: STAA) financial performance, stock price data, and analyst forecasts. It covers key metrics such as current stock price, historical highs and lows, market capitalization, volatility, and details on its latest ea", "url": "https://www.tradingview.com/symbols/NASDAQ-STAA/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T03:40:50", "published_display": "26 Jun 2026 03:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of STAAR Surgical Company \u2013 NASDAQ:STAA", "summary": "This page provides financial data for STAAR Surgical Company (NASDAQ: STAA), specifically focusing on its price-to-book forward ratio. The content seems to be an excerpt from a financial data platform, likely TradingView, presenting the stock's financial overview without detailed", "url": "https://www.tradingview.com/symbols/NASDAQ-STAA/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T03:27:36", "published_display": "26 Jun 2026 03:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What STAAR Surgical (STAA)'s New Shelf Registration and Equity Plan Expansion Means For Shareholders", "summary": "STAAR Surgical (STAA) recently filed a US$110.604 million shelf registration for 3,900,000 common shares and expanded its Omnibus Equity Incentive Plan by the same amount following shareholder approval. This move aims to provide financial flexibility and align leadership incentiv", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-staa/staar-surgical/news/what-staar-surgical-staas-new-shelf-registration-and-equity", "source_name": "Simply Wall Street", "published_at": "2026-06-25T12:39:21", "published_display": "25 Jun 2026 12:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Staar Surgical Shareholders Approve Expanded Equity Incentive Plan", "summary": "Staar Surgical shareholders approved an expanded equity incentive plan, reserving an additional 3.9 million shares for issuance, during their 2026 Annual Meeting. They also re-elected seven directors and ratified BDO USA, P.C. as the independent registered public accounting firm.", "url": "https://www.theglobeandmail.com/investing/markets/stocks/STAA/pressreleases/2613616/staar-surgical-shareholders-approve-expanded-equity-incentive-plan/", "source_name": "The Globe and Mail", "published_at": "2026-06-24T17:09:32", "published_display": "24 Jun 2026 17:09", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director of STAAR Surgical (NASDAQ: STAA) receives grant of 11,145 stock options", "summary": "Christopher Min Fang Wang, a director of STAAR Surgical (NASDAQ: STAA), was granted 11,145 stock options with an exercise price of $29.12 per share. These options are part of his compensation, not an open-market transaction, and will vest fully on the earlier of June 18, 2027, or", "url": "https://www.stocktitan.net/sec-filings/STAA/form-4-staar-surgical-co-insider-trading-activity-ee6937988588.html", "source_name": "Stock Titan", "published_at": "2026-06-23T20:40:37", "published_display": "23 Jun 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 STAAR Surgical Company For: 23 June By Investing.com", "summary": "This article reports on a Form 4 filing for STAAR Surgical Company (STAA) dated June 23. This financial filing indicates insider transactions or changes in beneficial ownership. The article also provides key market data, including various indices, commodities, and stock performan", "url": "https://ca.investing.com/news/stock-market-news/form-4-staar-surgical-company-for-23-june-93CH-4703996", "source_name": "Investing.com Canada", "published_at": "2026-06-23T20:40:37", "published_display": "23 Jun 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director Neal Bradsher granted 11,145 STAAR Surgical (STAA) stock options", "summary": "STAAR Surgical director Neal C. Bradsher received a grant of 11,145 stock options as director compensation. The options have an exercise price of $29.12 per share and will expire on June 18, 2036. They will vest on the earlier of June 18, 2027, or the company's next annual shareh", "url": "https://www.stocktitan.net/sec-filings/STAA/form-4-staar-surgical-co-insider-trading-activity-ea83b29de9cb.html", "source_name": "Stock Titan", "published_at": "2026-06-23T03:40:36", "published_display": "23 Jun 2026 03:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 STAAR Surgical Company For: 22 June By Investing.com", "summary": "This article reports on the filing of a Form 4 for STAAR Surgical Company on June 22nd, as noted by Investing.com. A Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) whenever there is a change in the beneficial ownership of a company'", "url": "https://ca.investing.com/news/stock-market-news/form-4-staar-surgical-company-for-22-june-93CH-4702223", "source_name": "Investing.com Canada", "published_at": "2026-06-23T00:11:00", "published_display": "23 Jun 2026 00:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAAR Surgical (STAA) director awarded 11,145 stock options at $29.12 strike", "summary": "STAAR Surgical director Richard T. LeBuhn was granted 11,145 stock options at an exercise price of $29.12 per share as part of his director compensation. These options will vest by June 18, 2027, or the company's next annual shareholder meeting, contingent on his continued servic", "url": "https://www.stocktitan.net/sec-filings/STAA/form-4-staar-surgical-co-insider-trading-activity-bf4f2a829e54.html", "source_name": "Stock Titan", "published_at": "2026-06-22T23:11:00", "published_display": "22 Jun 2026 23:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intraocular Lens Market to Witness Transformational Growth Opportunities by 2032 \u2013 DelveInsight | Johnson & Johnson, Alcon, Bausch & Lomb, ZEISS Group, STAAR Surgical, Hoya Corporation", "summary": "The global Intraocular Lens (IOL) market, valued at USD 4,648.96 million in 2024, is projected to reach USD 7,414.66 million by 2032, driven by increasing eye-related disorders, technological advancements, and rising awareness. Key players like Johnson & Johnson, Alcon, and Bausc", "url": "https://www.barchart.com/story/news/2592031/intraocular-lens-market-to-witness-transformational-growth-opportunities-by-2032-delveinsight-johnson-johnson-alcon-bausch-lomb-zeiss-group-staar-surgical-hoya-corporation", "source_name": "Barchart.com", "published_at": "2026-06-22T22:11:00", "published_display": "22 Jun 2026 22:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 4] STAAR SURGICAL CO Insider Trading Activity", "summary": "STAAR Surgical director Lilian Yansheng Zhou reported acquisition or exercise transactions in a Form 4 filing. Zhou received new equity awards, including options to purchase 5,572 shares at $29.12 and 3,091 restricted stock units, as part of the company\u2019s annual non-employee dire", "url": "https://www.stocktitan.net/sec-filings/STAA/form-4-staar-surgical-co-insider-trading-activity-155b86ebc08c.html", "source_name": "Stock Titan", "published_at": "2026-06-22T20:11:00", "published_display": "22 Jun 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAAR Surgical (STAA) adds 3.9M plan shares, elects board and ratifies BDO", "summary": "STAAR Surgical Company's shareholders approved substantial measures at their 2026 Annual Meeting. They voted to increase the shares reserved for their Omnibus Equity Incentive Plan by 3.9 million, elected seven directors, and ratified BDO USA, P.C. as the independent public accou", "url": "https://www.stocktitan.net/sec-filings/STAA/8-k-staar-surgical-co-reports-material-event-aaaa9a52ab65.html", "source_name": "Stock Titan", "published_at": "2026-06-22T20:11:00", "published_display": "22 Jun 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Staar Surgical | 4: Statement of changes in beneficial ownership of securities-Director BROADWOOD PARTNERS, L.P.", "summary": "This document is a statement of changes in beneficial ownership of securities for Staar Surgical, specifically related to Director BROADWOOD PARTNERS, L.P. It is a mandatory filing to report transactions involving company stock by insiders.", "url": "https://www.moomoo.com/news/notice/306661725/staar-surgical-4-statement-of-changes-in-beneficial-ownership-of", "source_name": "Moomoo", "published_at": "2026-06-19T13:10:47", "published_display": "19 Jun 2026 13:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAAR Surgical Co (STAA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a brief overview of STAAR Surgical Co (STAA)'s revenue breakdown by region. As of the updated figures on April 6, the company's revenue primarily comes from \"Others\" (39.19%), China (32.48%), Japan (18.90%), and the U.S. (9.42%). The article notes that relev", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-staa/revenue", "source_name": "TradingKey", "published_at": "2026-06-18T05:39:01", "published_display": "18 Jun 2026 05:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAAR Surgical (STAA) Stock Could Be 4.4% Undervalued Despite Its Rich P S Multiple", "summary": "STAAR Surgical (STAA) is viewed as potentially 4.4% undervalued based on a fair value estimate of $29.67 compared to its current price of $28.37, despite a rich P/S multiple of 4.9x, which is higher than peers and the industry average. The company has strong cash reserves and no ", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-staa/staar-surgical/news/staar-surgical-staa-stock-could-be-44-undervalued-despite-it", "source_name": "Simply Wall Street", "published_at": "2026-06-17T01:39:32", "published_display": "17 Jun 2026 01:39", "sentiment": "positive", "sentiment_pct": 62, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director Lilian Zhou of STAAR Surgical (STAA) receives 3,530-share stock award", "summary": "STAAR Surgical director Lilian Yansheng Zhou was awarded 3,530 shares of common stock on June 12, 2026, as a grant or award-type transaction. The shares were valued at a weighted average price of $28.2904, based on multiple trades between $28.215 and $28.35. Following this acquis", "url": "https://www.stocktitan.net/sec-filings/STAA/form-4-staar-surgical-co-insider-trading-activity-46fb00f5bbad.html", "source_name": "Stock Titan", "published_at": "2026-06-15T20:38:55", "published_display": "15 Jun 2026 20:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAAR Surgical\u2019s Standout Q1 Raises Questions On Sustainability And Valuation", "summary": "STAAR Surgical reported outstanding Q1 results with a 120% revenue increase year-on-year, significantly beating analyst estimates and demonstrating strong business momentum. Despite the strong performance, the stock's recent momentum is down 11.5% over the last 30 days, and its v", "url": "https://www.sahmcapital.com/news/content/staar-surgicals-standout-q1-raises-questions-on-sustainability-and-valuation-2026-06-14", "source_name": "Sahm", "published_at": "2026-06-14T12:39:01", "published_display": "14 Jun 2026 12:39", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAAR Surgical Company Stock 12\u2011Month Price Target Raised to $30.5, Implies 6% Upside", "summary": "STAAR Surgical Company's average 12-month price target has been increased from $29.67 to $30.5 by 8 analysts, suggesting a 6% potential upside from its June 11 closing price. The consensus rating among 11 covering analysts has shifted to \"Buy\", comprising 3 Buys, 8 Holds, and 0 S", "url": "https://www.tradingview.com/news/tradingview:69d6a7e7c478e:0-staar-surgical-company-stock-12-month-price-target-raised-to-30-5-implies-6-upside/", "source_name": "TradingView", "published_at": "2026-06-12T04:09:09", "published_display": "12 Jun 2026 04:09", "sentiment": "positive", "sentiment_pct": 73, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Stocks Q1 Earnings: STAAR Surgical (NASDAQ:STAA) Firing on All Cylinders", "summary": "STAAR Surgical (NASDAQ:STAA) reported strong Q1 earnings, with revenues up 120% year-on-year, significantly exceeding analyst expectations. This performance made it the top performer among its peers in the medical devices & supplies specialty sector, which as a group also saw rev", "url": "https://stockstory.org/us/stocks/nasdaq/staa/news/earnings/medical-devices-and-supplies-specialty-stocks-q1-earnings-staar-surgical-nasdaqstaa-firing-on-all-cylinders", "source_name": "StockStory", "published_at": "2026-06-11T22:09:19", "published_display": "11 Jun 2026 22:09", "sentiment": "positive", "sentiment_pct": 67, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAAR Surgical Raises Pay for Interim Co-CEO Andrews", "summary": "STAAR Surgical (STAA) has increased the annual base salary of Interim Co-CEO and CFO Deborah Andrews from $512,000 to $575,000, and her target annual cash bonus from 55% to 60% of base salary, effective June 8, 2026. These adjustments reflect competitive market data and recogniti", "url": "https://www.theglobeandmail.com/investing/markets/stocks/STAA-Q/pressreleases/2409399/staar-surgical-raises-pay-for-interim-co-ceo-andrews/", "source_name": "The Globe and Mail", "published_at": "2026-06-10T23:38:55", "published_display": "10 Jun 2026 23:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CenterBook Partners LP Buys New Position in STAAR Surgical Company $STAA", "summary": "CenterBook Partners LP has acquired a new position in STAAR Surgical Company, purchasing 177,974 shares valued at approximately $4.1 million in the fourth quarter. This move comes as STAAR Surgical reported strong quarterly earnings of $0.10 per share and revenue of $93.52 millio", "url": "https://www.marketbeat.com/instant-alerts/filing-centerbook-partners-lp-buys-new-position-in-staar-surgical-company-staa-2026-06-09/", "source_name": "MarketBeat", "published_at": "2026-06-09T21:40:23", "published_display": "09 Jun 2026 21:40", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The STAAR Surgical (STAA) Story Is Shifting After Q1 And New Analyst Targets", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQUUk1WlEtUUtkVWdmM1pscHZXSkJYY09oM1VUUmtzVVdhVFhfNGNkOUhHZnl4WndaQmQ5V0IzUXRoY2hQSHA3YTlfc1JSTFhtQl9udldJZDRxSkNtaUpvMm9lNDBjUXdKQ214YkFpN2tqVDA0S0ltWldjMktMaHNTVkg0S3F6SjNnbTF3czFoM1dJLVRTdEx5anZoS3ZxcXRR?oc=5", "source_name": "Market source", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hedge Fund Broadwood Capital Added Over 1 Million Shares of STAAR Surgical to Its Position. Here's What That Means for Investors.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAJBVV95cUxPYW0yLTNFSGJrTzlaNzlRcUl0QWVFNnk2QzVjWVZ3NnQycGw3cGNyWkZ3SVc3eFBJakd1Y1RQYVVXLUJDV2lURlU5Vml6ODMyZ0tyWjVSbVBnd3pkV0FBM21QVkk1U2hQTXlheEwwZmxFMmtvV1pLY0EzLTlCdk5IaGt1Q1lHbkF2aENTLU5NVnZwMjd5Qno2YjZjUGs1a01LSkVpaUhXaVpUVTV1TEthX2J6ZG5lTmdyX0Jza2FEdks5bzdCUmVoczZaUTdNMXhjbnJrcmw4MDVGaVNqNmpqTS1yYnhiQldHVk90SGotRWlQcHlJX0hnM09fdHY3SENhSno0eVp5Q3k?oc=5", "source_name": "The Motley Fool", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAAR Surgical signals standalone strength as Alcon overhang fades after strong Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxQOXN3aGpSLVB0ZjVueXRZMUp6WWVvOUtmN3lfaWYzeXNRZlV2NllIWmMtR0swRTJGQkR1RWVvNk5jNjRodEhOX0R4aFRwdWZlUzFpSmRmeHRCd3hzNkE1eVE1ekVxVlJOZ1ZJMGVwOEdhLVMyb25hU0RTMEcxbUVsS3Jqa2J5UkNKdU9kMW5uTTFsYmFvcW1uQWF2bGs2SG1ocjJoXzFKZklxTTltTUJEVGVHQjlwbnlBYVl3SGdOQUxGZ0tCaEJQV0YzS1FaNjItdXhHVHhn?oc=5", "source_name": "Investing.com", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "5 Must-Read Analyst Questions From STAAR Surgical\u2019s Q1 Earnings Call", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPQmhRZndEX182RFY5OEpBZEhlZlJnWk52TkJHS1FjZFY1Vkk1al9nVnNtTXo2X2VoVUJmODhRWV9IdEZIZmI3cmY4Wkd5VWx2aHptVGFiMlZsa0Q2c3JQVVZJU3RzSTBSNmh0TEVJakZNaWF4NDkwUnFUUVBaMnJOeHhKRnphVWVVWGpwUHRMR0s4YWNITG5oeWV3TnZkVWs3WnZ4bzc3Zi1pSDQwU1ZqUDFPNFJtRzJoa3dOUU1PSUlTVUo3T01BRQ?oc=5", "source_name": "TradingView", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAAR Surgical Q1 2026: Early Signs Of A Durable Turnaround", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxNUDBUeXNMT010RGhCOXZlbnlZeS01bGpPT0RuTGdqNHY5bmpoTVdTa1MteFZsUFhnNy1mN3hWaE1lV2RqcjFEYVlLWEFUYml4b1c1emxBNWRFaTZmb2xfTXM3MjVuWDFER1JTSHRhaUVBT3lZWTlFYjdqQTgwUUhYcjc5QzJ5RzBOc1ZrMnBzOWI4R0dKZnRINkNCcmY?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-16T07:00:00+00:00", "published_display": "16 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAAR Surgical (STAA) Is Up 5.9% After Returning To Quarterly Profitability - What's Changed", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxOUU1iRUdMMHlxZ1lnTGl0cUd5WHFKZjREYjAya0lFTzUxM05yRE15eW50T2VaWU1nWlBKU3g3blZSR3NXc1NzMGJySXR2VFJUcEkyaFkwSEtEcmJSRnFEakQtT1JvWXpzVVJFYS1QMXJRUkRoQk5QWU9iRURYLUprNHFmR0JVTW5mTUVlR3BsU0o1SXM4MVRV?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAAR Surgical (NASDAQ:STAA) Beats Expectations in Strong Q1 CY2026, Stock Jumps 18.3%", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxQY0xNeXJabVY3amNPbUpRcFZTV3BsMlBmMnkybE5SSGlvRmJNVXViU0dvM0NnNWJlM0ZpcEJRMlVUUEFpRGtRZHVjdF8wT0ZIdE15X2RBVWhpd0RWaDlocGpUbzlQa1YzY1dBRlhHNnZCUmc2YmxGeXhSNkxSZ0YxQjlZU0xNNXBIM2lpTGpZdFZSWEt4Tkg0WmhpSEtTSXplTllNbV9BTm9iOTkxaFVGclYzLUI0VWd3ODFqbWF5YlZzaG5zOGkxd1dIMjFtMHVhU3VjeWdFY2R3U29GOFhZ?oc=5", "source_name": "StockStory", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Staar Surgical (STAA) Tops Q1 Earnings and Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNODAtazJsMnRnejJEOHZRa25wTThQUmpsLVE0T0tINU5MZGhWd0N2VGpqcDlMM20xVTRJN1Z5UTg0dXVCclZyN191V01iNVNVazh0bWcyRmdaT3gtNWpUMkZDVl9xS21kTzlsQjU1MXBvdy1sZVBUdk04NmdRTWVxclpEVHIwRVhESGRBTHFTaURNWkt3RWZ3?oc=5", "source_name": "Market source", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAAR Surgical Co stock (US8577001096): Up 2.35% among top monthly gainers", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQWldleDAyTkQ0WFAzTDR4bkRlUUJDRkNuTUo2cG5fUWdJVG9EUk1udnphRFJxZDJvWF9nNHliS0JyOHp4WFh5RExsM0kyYXpGZ1p3U2dfMGRvX2swN3ZSX0tvX1hrM3QyWU5rMmJ6cjhkN2dMMzRJakFOb1lDNnBVLUxrT3BJeDJQZzQ2THd6eDVtMkV5ek5yc0JndlZMdVdlT0dfcW5MbDFVOTNkeVJLX2NXOUJ0dUJaN1BYaGRIYU5taUZ6Z0xOaw?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[SCHEDULE 13G] STAAR SURGICAL CO Passive Investment Disclosure (>5%)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOX0MtenViNV91TUVCY3Vndm9zN3dnTnJTdWY4Yk1uaXpNc2MyS0o0S3pLSEYtblUtYVlWVElYMEMzd2pmWFdoODR6VjlYeFZReEJETHJhNkRyX2g1ZW9SeTNwb0lmcWtrQ0QzNXhYc1VicWtEclVNTFh0QlRrSEdsN3ZHaEFrdktWSGRCcWdaZ0dkOFUzY0JhZ2dlTDBVT3pNWnhyaVV1NWJfWWpjZDVyS1Q3RTZHY0FPSTJsbU5tNDhTQQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Too Late To Consider STAAR Surgical (STAA) After Its Recent 1 Year Share Price Surge?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAAR Surgical: Q1 Preliminary Revenues Justify Decision To Reject Alcon Bid (NASDAQ:STAA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPQVVELWpTN3dFS082MUZFQ085SkoxeEc3a2FiTkNSTm1CdnZ1NU8yb20xdUprQUR4ODVfQ3Nfdy1xcEdrbnpXZFVlV0Z5bkRuVnpYYUxPZlZ3LUhwZ2xmY3pBYmt4bmdSN21JZ1lUQ2ZmZ201SERrWV9jR3o2eG85UWpuYVBVcURMejBqaVlrRzNuVmktRHJocHVRNFpOZmtVcV9ZVXgzd2xwamNsd21JQk0yZ2sydFU?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-09T07:00:00+00:00", "published_display": "09 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAAR Surgical (STAA) Is Up 8.0% After Q1 2026 Sales More Than Double - What's Changed", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxPd1NlbGc5T3dMQndfSUdSZTZBM2hGYnl2cWxVNDNINkhaVW9Lc0hmWk5yd0R4UVllcUdlTFoyQXd4QmUzN21TN1E4dFBtdlpKMzhNV3duVVVoR3dqNkdRUU5xVDhXNXFPX2hoSGZyU1Z5X3lBQ1U0SnAwWHVaQ1ZrSEdwUUNDMVNPODJrVVpoRm5EQQ?oc=5", "source_name": "Market source", "published_at": "2026-04-09T07:00:00+00:00", "published_display": "09 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China drives STAAR Surgical sales above $90M in early 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxOVS1FZkdqQTZHTUZTY2dQSVJPcWROdGhDRkJIUWdPZ0pwSDFIVHBGZnBKUFJwbDNBMGEtVmM5S0d5cXpIanVFSFlHZk1zYXF2OTdodllXUVM3bm4zajBKWktyMHUzM3czRlR0bHpxcVBTbngtUmhxZUc2a0l1VnhXamxkY09zdWo3Yjc3X3J6aDhrYldhaGVORXFVUXIzYWFoM1hlS0hoS0JhU2QwalZOUXV3S3E3Y0lTRXEw?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-08T07:00:00+00:00", "published_display": "08 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surging Earnings Estimates Signal Upside for Staar Surgical (STAA) Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPT2Q5LU5PRzJPenExTFlheWtNeVpXeVdPSW05Ykg1ODdldVJGLWtDSU1rSEw4aGpwejdnN0YzaklMOFZMdUNaaEc2WU82RmUzYTFyUHl4T1FwUk9pRXVHbDBBM3NjbUEwQVc1c290b3gyeVROWVRxazdLSzNIMlJWckM4aDhDY05oNGM3V2V2OWNGM2E3bGlaUWZUaGVpblBnQmRTTWxoNHc?oc=5", "source_name": "Market source", "published_at": "2026-04-06T07:00:00+00:00", "published_display": "06 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why STAAR Surgical (STAA) Stock Is Trading Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQRzBvSXJzcUV0ZHFRbzF5djJUV0psUWhNUGl5Mko2aG9mTWo3cmt2aWRVYVBCWktfdHYyRTFxUFc1ZGViTnc1TnFGYWMtUWp2R1lTSERkczExeE02UlRLNVE5V1FEaVFXclduUW1mZFNObmd2UlJOeHJHMkF0akY2c01ka2tBRjU3WDctUU5PLUlkbS1TUHRDd2d0MXB2Q2Fac3N6dUxKLWM0UUhDRXJ4bA?oc=5", "source_name": "StockStory", "published_at": "2026-03-24T07:00:00+00:00", "published_display": "24 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAAR Surgical Reports Fourth Quarter and Fiscal Year 2025 Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxOdWtCR1lLcXlJcGJuNlpPS3VUdzVFMExmcTN0UWVaRHBPNXhKa3IxOHVmd3NMYTA4SWhuWUNPNjd4bUpFcXdDdG1mOHNwbGNrby1SWDVodGJNcHdDRGNzQVVMYUhTMjRpNGdHZDQ1b21xTUl5OGxEa3FaLXNnTk5kMks1VmcxX290WU5PWTktQnhwWWNtWURteU1pLXNhTDY3TEw5MnVvVGVSUUNQQ1ZrVDV3ODZGM1c3OEx0NUJJNGM?oc=5", "source_name": "Business Wire", "published_at": "2026-03-03T08:00:00+00:00", "published_display": "03 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAAR Surgical (NASDAQ:STAA) Misses Q4 CY2025 Sales Expectations, Stock Drops 11.2%", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMXNoRHNGOVl2UW5lclZtUzhhV2tQTHRzYVVidTF3N0lSZXpaMDJESmR2TncxYTJxbnJUQ2FNckZ4NWRRUThZSUZxQzRyQXBwVzVIdURObkxXQ2xmbVhaOURONlc3QUdiZ3ZaNmFMQlBIY3o2SkhxSEdqZ05TamRjWHdIeElndw?oc=5", "source_name": "Market source", "published_at": "2026-03-03T08:00:00+00:00", "published_display": "03 Mar 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Question STAAR Surgical Company (STAA)\u2019s Post-Merger Standalone Valuation", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxQUzFhWUJLdVZqQXVaOGtnOVJqVlduN0pQVG9tNU9IVjdlOFo5TnBlaUQxblc0ZXhxc21CLXV0MG9qWDlORldUcnVPbUVpbVd1eGhlbWpEZ2RoSHFZWXBlWEhieC1hU0RtQ2g5ZDBzeDZjSzNJNGNwbFZ5YTctbV9tbGUzSUJ1MmYtOFE?oc=5", "source_name": "Market source", "published_at": "2026-01-25T08:00:00+00:00", "published_display": "25 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAAR Surgical terminates proposed acquisition by Alcon", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNM2E3UDJYenlGSDlKX0lHdmRScEdXT3F1OG1xajdKd2JXSE9UZ20xX1JUWS1Gc0V2X05RT2M1MTB3MlQ5a2lnRDUtWXJmcGN4NzE5ZFYxaVdBX0FQb1A2MXZpLXFDemk0VGt4TVVGQ0xITElUdDMxUk9FaHFxVkFlOEhjZU5VTmUzLV9Vd0FtVGdqYTBnWUtnUEk4SQ?oc=5", "source_name": "Ophthalmology Times Europe", "published_at": "2026-01-06T08:00:00+00:00", "published_display": "06 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Staar Surgical's China ICL Demand Driven by Macro Affordability Pressures, Wedbush Says", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxPbjBNem1pcXQ2UGprT3M5T3JLYkI3eXNobHFnU3JrdFZNWFpSS2RMUEVacmV5VHRZOHptX09sNmtrdXRuckdUUE1MclJ4X2JlMUVrX2hrd0ctX21TaXNGOFAzSGItVTNvMC0xcF95YThOUmhsMGlNWGpDdklSRV92UTFlNzhyYWd3aGl5U2JnRDlmTFFMWTVPSkVFbEp5TWpfRXd1dlZTVjdOaWxzZ0hvb0pUeEZtUnJ4VEtoZlFZUEdfWThDTGtBcWhRc0JIZWVmX3EwVEhR?oc=5", "source_name": "marketscreener.com", "published_at": "2026-07-15T14:54:16+00:00", "published_display": "15 Jul 2026 14:54", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Trading Systems Reacting to (STAA) Volatility", "summary": "Staar Surgical Company (NASDAQ: STAA) is exhibiting weak near and mid-term sentiment, potentially pressuring a neutral long-term outlook. AI models have generated three distinct trading strategies\u2014Position Trading, Momentum Breakout, and Risk Hedging\u2014to capitalize on a mid-channe", "url": "https://news.stocktradersdaily.com/news_release/90/Trading_Systems_Reacting_to_STAA_Volatility_071026043602_1783672562.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-10T04:10:31", "published_display": "10 Jul 2026 04:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAA Stock On Track For Its Fourth Straight Session Of Gains \u2013 This Analyst Would Rather Be Early Than Late On Staar\u2019s Growth Story", "summary": "Shares of Staar Surgical (STAA) rose over 10% after strong first-quarter results led multiple analysts to issue bullish ratings. Wedbush upgraded STAA to 'Outperform' with a $40 price target, citing a potential full China rebound and long-term growth exceeding expectations. Canac", "url": "https://stocktwits.com/news-articles/markets/equity/staa-stock-on-track-for-its-fourth-straight-session-of-gains-earnings-analysts-upgrade-stock/cZX1wjjReSd", "source_name": "Stocktwits", "published_at": "2026-07-09T16:10:31", "published_display": "09 Jul 2026 16:10", "sentiment": "positive", "sentiment_pct": 86, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Heidelberg Engineering, STAAR, Ziemer to showcase latest technologies at ESCRS 2025", "summary": "Heidelberg Engineering, STAAR Surgical, and Ziemer Ophthalmic Systems are set to present their latest advancements in cataract and refractive surgery at the 43rd ESCRS Congress in Copenhagen. Heidelberg Engineering will launch a new ANTERION software update with improved cataract", "url": "https://www.ophthalmologytimes.com/view/heidelberg-staar-ziemer-showcase-latest-technologies-cataract-refractive-escrs-2025", "source_name": "Ophthalmology Times", "published_at": "2026-07-08T01:09:30", "published_display": "08 Jul 2026 01:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAAR Surgical Co highlights its vision correction technology as investors weigh long-term growth", "summary": "STAAR Surgical Co (ISIN US8577001096) specializes in implantable collamer lenses for refractive vision correction, positioning itself in the growing market for advanced eye surgery. The company's business model focuses on supplying high-value medical devices to eye care professio", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/staar-surgical-co-highlights-its-vision-correction-technology-as-investors/69714273", "source_name": "AD HOC NEWS", "published_at": "2026-07-07T14:47:00", "published_display": "07 Jul 2026 14:47", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "3 Reasons to Avoid STAA and 1 Stock to Buy Instead", "summary": "This article recommends avoiding STAAR Surgical (STAA) despite its recent stock gains, citing three main reasons: declining revenue, a dropping free cash flow margin, and a decrease in Return on Invested Capital (ROIC). The author suggests better investment opportunities exist an", "url": "https://stockstory.org/us/stocks/nasdaq/staa/news/buy-or-sell/3-reasons-to-avoid-staa-and-1-stock-to-buy-instead-5", "source_name": "StockStory", "published_at": "2026-07-02T19:09:51", "published_display": "02 Jul 2026 19:09", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Staar Surgical Company (STAA) Affects Rotational Strategy Timing", "summary": "This article analyzes Staar Surgical Company (STAA) through an AI model, revealing strong near-term sentiment but neutral mid and long-term outlooks. It highlights a significant short setup with a 67.7:1 risk-reward ratio targeting a 19.2% downside. The analysis provides three in", "url": "https://news.stocktradersdaily.com/news_release/98/How_Staar_Surgical_Company_STAA_Affects_Rotational_Strategy_Timing_062926032802_1782718082.html", "source_name": "Stock Traders Daily", "published_at": "2026-06-29T03:28:00", "published_display": "29 Jun 2026 03:28", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAAR Surgical Company Actuals & Estimates (NASDAQ:STAA)", "summary": "This article provides an overview of STAAR Surgical Company (NASDAQ: STAA) financial performance, stock price data, and analyst forecasts. It covers key metrics such as current stock price, historical highs and lows, market capitalization, volatility, and details on its latest ea", "url": "https://www.tradingview.com/symbols/NASDAQ-STAA/forecast-actuals-and-estimates/", "source_name": "TradingView", "published_at": "2026-06-26T03:40:50", "published_display": "26 Jun 2026 03:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of STAAR Surgical Company \u2013 NASDAQ:STAA", "summary": "This page provides financial data for STAAR Surgical Company (NASDAQ: STAA), specifically focusing on its price-to-book forward ratio. The content seems to be an excerpt from a financial data platform, likely TradingView, presenting the stock's financial overview without detailed", "url": "https://www.tradingview.com/symbols/NASDAQ-STAA/financials-statistics-and-ratios/price-book-fwd/", "source_name": "TradingView", "published_at": "2026-06-26T03:27:36", "published_display": "26 Jun 2026 03:27", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What STAAR Surgical (STAA)'s New Shelf Registration and Equity Plan Expansion Means For Shareholders", "summary": "STAAR Surgical (STAA) recently filed a US$110.604 million shelf registration for 3,900,000 common shares and expanded its Omnibus Equity Incentive Plan by the same amount following shareholder approval. This move aims to provide financial flexibility and align leadership incentiv", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-staa/staar-surgical/news/what-staar-surgical-staas-new-shelf-registration-and-equity", "source_name": "Simply Wall Street", "published_at": "2026-06-25T12:39:21", "published_display": "25 Jun 2026 12:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Staar Surgical Shareholders Approve Expanded Equity Incentive Plan", "summary": "Staar Surgical shareholders approved an expanded equity incentive plan, reserving an additional 3.9 million shares for issuance, during their 2026 Annual Meeting. They also re-elected seven directors and ratified BDO USA, P.C. as the independent registered public accounting firm.", "url": "https://www.theglobeandmail.com/investing/markets/stocks/STAA/pressreleases/2613616/staar-surgical-shareholders-approve-expanded-equity-incentive-plan/", "source_name": "The Globe and Mail", "published_at": "2026-06-24T17:09:32", "published_display": "24 Jun 2026 17:09", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director of STAAR Surgical (NASDAQ: STAA) receives grant of 11,145 stock options", "summary": "Christopher Min Fang Wang, a director of STAAR Surgical (NASDAQ: STAA), was granted 11,145 stock options with an exercise price of $29.12 per share. These options are part of his compensation, not an open-market transaction, and will vest fully on the earlier of June 18, 2027, or", "url": "https://www.stocktitan.net/sec-filings/STAA/form-4-staar-surgical-co-insider-trading-activity-ee6937988588.html", "source_name": "Stock Titan", "published_at": "2026-06-23T20:40:37", "published_display": "23 Jun 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 STAAR Surgical Company For: 23 June By Investing.com", "summary": "This article reports on a Form 4 filing for STAAR Surgical Company (STAA) dated June 23. This financial filing indicates insider transactions or changes in beneficial ownership. The article also provides key market data, including various indices, commodities, and stock performan", "url": "https://ca.investing.com/news/stock-market-news/form-4-staar-surgical-company-for-23-june-93CH-4703996", "source_name": "Investing.com Canada", "published_at": "2026-06-23T20:40:37", "published_display": "23 Jun 2026 20:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director Neal Bradsher granted 11,145 STAAR Surgical (STAA) stock options", "summary": "STAAR Surgical director Neal C. Bradsher received a grant of 11,145 stock options as director compensation. The options have an exercise price of $29.12 per share and will expire on June 18, 2036. They will vest on the earlier of June 18, 2027, or the company's next annual shareh", "url": "https://www.stocktitan.net/sec-filings/STAA/form-4-staar-surgical-co-insider-trading-activity-ea83b29de9cb.html", "source_name": "Stock Titan", "published_at": "2026-06-23T03:40:36", "published_display": "23 Jun 2026 03:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 STAAR Surgical Company For: 22 June By Investing.com", "summary": "This article reports on the filing of a Form 4 for STAAR Surgical Company on June 22nd, as noted by Investing.com. A Form 4 is a document that must be filed with the U.S. Securities and Exchange Commission (SEC) whenever there is a change in the beneficial ownership of a company'", "url": "https://ca.investing.com/news/stock-market-news/form-4-staar-surgical-company-for-22-june-93CH-4702223", "source_name": "Investing.com Canada", "published_at": "2026-06-23T00:11:00", "published_display": "23 Jun 2026 00:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAAR Surgical (STAA) director awarded 11,145 stock options at $29.12 strike", "summary": "STAAR Surgical director Richard T. LeBuhn was granted 11,145 stock options at an exercise price of $29.12 per share as part of his director compensation. These options will vest by June 18, 2027, or the company's next annual shareholder meeting, contingent on his continued servic", "url": "https://www.stocktitan.net/sec-filings/STAA/form-4-staar-surgical-co-insider-trading-activity-bf4f2a829e54.html", "source_name": "Stock Titan", "published_at": "2026-06-22T23:11:00", "published_display": "22 Jun 2026 23:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Intraocular Lens Market to Witness Transformational Growth Opportunities by 2032 \u2013 DelveInsight | Johnson & Johnson, Alcon, Bausch & Lomb, ZEISS Group, STAAR Surgical, Hoya Corporation", "summary": "The global Intraocular Lens (IOL) market, valued at USD 4,648.96 million in 2024, is projected to reach USD 7,414.66 million by 2032, driven by increasing eye-related disorders, technological advancements, and rising awareness. Key players like Johnson & Johnson, Alcon, and Bausc", "url": "https://www.barchart.com/story/news/2592031/intraocular-lens-market-to-witness-transformational-growth-opportunities-by-2032-delveinsight-johnson-johnson-alcon-bausch-lomb-zeiss-group-staar-surgical-hoya-corporation", "source_name": "Barchart.com", "published_at": "2026-06-22T22:11:00", "published_display": "22 Jun 2026 22:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[Form 4] STAAR SURGICAL CO Insider Trading Activity", "summary": "STAAR Surgical director Lilian Yansheng Zhou reported acquisition or exercise transactions in a Form 4 filing. Zhou received new equity awards, including options to purchase 5,572 shares at $29.12 and 3,091 restricted stock units, as part of the company\u2019s annual non-employee dire", "url": "https://www.stocktitan.net/sec-filings/STAA/form-4-staar-surgical-co-insider-trading-activity-155b86ebc08c.html", "source_name": "Stock Titan", "published_at": "2026-06-22T20:11:00", "published_display": "22 Jun 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAAR Surgical (STAA) adds 3.9M plan shares, elects board and ratifies BDO", "summary": "STAAR Surgical Company's shareholders approved substantial measures at their 2026 Annual Meeting. They voted to increase the shares reserved for their Omnibus Equity Incentive Plan by 3.9 million, elected seven directors, and ratified BDO USA, P.C. as the independent public accou", "url": "https://www.stocktitan.net/sec-filings/STAA/8-k-staar-surgical-co-reports-material-event-aaaa9a52ab65.html", "source_name": "Stock Titan", "published_at": "2026-06-22T20:11:00", "published_display": "22 Jun 2026 20:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Staar Surgical | 4: Statement of changes in beneficial ownership of securities-Director BROADWOOD PARTNERS, L.P.", "summary": "This document is a statement of changes in beneficial ownership of securities for Staar Surgical, specifically related to Director BROADWOOD PARTNERS, L.P. It is a mandatory filing to report transactions involving company stock by insiders.", "url": "https://www.moomoo.com/news/notice/306661725/staar-surgical-4-statement-of-changes-in-beneficial-ownership-of", "source_name": "Moomoo", "published_at": "2026-06-19T13:10:47", "published_display": "19 Jun 2026 13:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAAR Surgical Co (STAA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a brief overview of STAAR Surgical Co (STAA)'s revenue breakdown by region. As of the updated figures on April 6, the company's revenue primarily comes from \"Others\" (39.19%), China (32.48%), Japan (18.90%), and the U.S. (9.42%). The article notes that relev", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-staa/revenue", "source_name": "TradingKey", "published_at": "2026-06-18T05:39:01", "published_display": "18 Jun 2026 05:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAAR Surgical (STAA) Stock Could Be 4.4% Undervalued Despite Its Rich P S Multiple", "summary": "STAAR Surgical (STAA) is viewed as potentially 4.4% undervalued based on a fair value estimate of $29.67 compared to its current price of $28.37, despite a rich P/S multiple of 4.9x, which is higher than peers and the industry average. The company has strong cash reserves and no ", "url": "https://simplywall.st/stocks/us/healthcare/nasdaq-staa/staar-surgical/news/staar-surgical-staa-stock-could-be-44-undervalued-despite-it", "source_name": "Simply Wall Street", "published_at": "2026-06-17T01:39:32", "published_display": "17 Jun 2026 01:39", "sentiment": "positive", "sentiment_pct": 62, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Director Lilian Zhou of STAAR Surgical (STAA) receives 3,530-share stock award", "summary": "STAAR Surgical director Lilian Yansheng Zhou was awarded 3,530 shares of common stock on June 12, 2026, as a grant or award-type transaction. The shares were valued at a weighted average price of $28.2904, based on multiple trades between $28.215 and $28.35. Following this acquis", "url": "https://www.stocktitan.net/sec-filings/STAA/form-4-staar-surgical-co-insider-trading-activity-46fb00f5bbad.html", "source_name": "Stock Titan", "published_at": "2026-06-15T20:38:55", "published_display": "15 Jun 2026 20:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAAR Surgical\u2019s Standout Q1 Raises Questions On Sustainability And Valuation", "summary": "STAAR Surgical reported outstanding Q1 results with a 120% revenue increase year-on-year, significantly beating analyst estimates and demonstrating strong business momentum. Despite the strong performance, the stock's recent momentum is down 11.5% over the last 30 days, and its v", "url": "https://www.sahmcapital.com/news/content/staar-surgicals-standout-q1-raises-questions-on-sustainability-and-valuation-2026-06-14", "source_name": "Sahm", "published_at": "2026-06-14T12:39:01", "published_display": "14 Jun 2026 12:39", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAAR Surgical Company Stock 12\u2011Month Price Target Raised to $30.5, Implies 6% Upside", "summary": "STAAR Surgical Company's average 12-month price target has been increased from $29.67 to $30.5 by 8 analysts, suggesting a 6% potential upside from its June 11 closing price. The consensus rating among 11 covering analysts has shifted to \"Buy\", comprising 3 Buys, 8 Holds, and 0 S", "url": "https://www.tradingview.com/news/tradingview:69d6a7e7c478e:0-staar-surgical-company-stock-12-month-price-target-raised-to-30-5-implies-6-upside/", "source_name": "TradingView", "published_at": "2026-06-12T04:09:09", "published_display": "12 Jun 2026 04:09", "sentiment": "positive", "sentiment_pct": 73, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Stocks Q1 Earnings: STAAR Surgical (NASDAQ:STAA) Firing on All Cylinders", "summary": "STAAR Surgical (NASDAQ:STAA) reported strong Q1 earnings, with revenues up 120% year-on-year, significantly exceeding analyst expectations. This performance made it the top performer among its peers in the medical devices & supplies specialty sector, which as a group also saw rev", "url": "https://stockstory.org/us/stocks/nasdaq/staa/news/earnings/medical-devices-and-supplies-specialty-stocks-q1-earnings-staar-surgical-nasdaqstaa-firing-on-all-cylinders", "source_name": "StockStory", "published_at": "2026-06-11T22:09:19", "published_display": "11 Jun 2026 22:09", "sentiment": "positive", "sentiment_pct": 67, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAAR Surgical Raises Pay for Interim Co-CEO Andrews", "summary": "STAAR Surgical (STAA) has increased the annual base salary of Interim Co-CEO and CFO Deborah Andrews from $512,000 to $575,000, and her target annual cash bonus from 55% to 60% of base salary, effective June 8, 2026. These adjustments reflect competitive market data and recogniti", "url": "https://www.theglobeandmail.com/investing/markets/stocks/STAA-Q/pressreleases/2409399/staar-surgical-raises-pay-for-interim-co-ceo-andrews/", "source_name": "The Globe and Mail", "published_at": "2026-06-10T23:38:55", "published_display": "10 Jun 2026 23:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CenterBook Partners LP Buys New Position in STAAR Surgical Company $STAA", "summary": "CenterBook Partners LP has acquired a new position in STAAR Surgical Company, purchasing 177,974 shares valued at approximately $4.1 million in the fourth quarter. This move comes as STAAR Surgical reported strong quarterly earnings of $0.10 per share and revenue of $93.52 millio", "url": "https://www.marketbeat.com/instant-alerts/filing-centerbook-partners-lp-buys-new-position-in-staar-surgical-company-staa-2026-06-09/", "source_name": "MarketBeat", "published_at": "2026-06-09T21:40:23", "published_display": "09 Jun 2026 21:40", "sentiment": "positive", "sentiment_pct": 64, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How The STAAR Surgical (STAA) Story Is Shifting After Q1 And New Analyst Targets", "summary": "", "url": "https://news.google.com/rss/articles/CBMioAFBVV95cUxQUUk1WlEtUUtkVWdmM1pscHZXSkJYY09oM1VUUmtzVVdhVFhfNGNkOUhHZnl4WndaQmQ5V0IzUXRoY2hQSHA3YTlfc1JSTFhtQl9udldJZDRxSkNtaUpvMm9lNDBjUXdKQ214YkFpN2tqVDA0S0ltWldjMktMaHNTVkg0S3F6SjNnbTF3czFoM1dJLVRTdEx5anZoS3ZxcXRR?oc=5", "source_name": "Market source", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Hedge Fund Broadwood Capital Added Over 1 Million Shares of STAAR Surgical to Its Position. Here's What That Means for Investors.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiiAJBVV95cUxPYW0yLTNFSGJrTzlaNzlRcUl0QWVFNnk2QzVjWVZ3NnQycGw3cGNyWkZ3SVc3eFBJakd1Y1RQYVVXLUJDV2lURlU5Vml6ODMyZ0tyWjVSbVBnd3pkV0FBM21QVkk1U2hQTXlheEwwZmxFMmtvV1pLY0EzLTlCdk5IaGt1Q1lHbkF2aENTLU5NVnZwMjd5Qno2YjZjUGs1a01LSkVpaUhXaVpUVTV1TEthX2J6ZG5lTmdyX0Jza2FEdks5bzdCUmVoczZaUTdNMXhjbnJrcmw4MDVGaVNqNmpqTS1yYnhiQldHVk90SGotRWlQcHlJX0hnM09fdHY3SENhSno0eVp5Q3k?oc=5", "source_name": "The Motley Fool", "published_at": "2026-06-01T07:00:00+00:00", "published_display": "01 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAAR Surgical signals standalone strength as Alcon overhang fades after strong Q1", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1gFBVV95cUxQOXN3aGpSLVB0ZjVueXRZMUp6WWVvOUtmN3lfaWYzeXNRZlV2NllIWmMtR0swRTJGQkR1RWVvNk5jNjRodEhOX0R4aFRwdWZlUzFpSmRmeHRCd3hzNkE1eVE1ekVxVlJOZ1ZJMGVwOEdhLVMyb25hU0RTMEcxbUVsS3Jqa2J5UkNKdU9kMW5uTTFsYmFvcW1uQWF2bGs2SG1ocjJoXzFKZklxTTltTUJEVGVHQjlwbnlBYVl3SGdOQUxGZ0tCaEJQV0YzS1FaNjItdXhHVHhn?oc=5", "source_name": "Investing.com", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "5 Must-Read Analyst Questions From STAAR Surgical\u2019s Q1 Earnings Call", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxPQmhRZndEX182RFY5OEpBZEhlZlJnWk52TkJHS1FjZFY1Vkk1al9nVnNtTXo2X2VoVUJmODhRWV9IdEZIZmI3cmY4Wkd5VWx2aHptVGFiMlZsa0Q2c3JQVVZJU3RzSTBSNmh0TEVJakZNaWF4NDkwUnFUUVBaMnJOeHhKRnphVWVVWGpwUHRMR0s4YWNITG5oeWV3TnZkVWs3WnZ4bzc3Zi1pSDQwU1ZqUDFPNFJtRzJoa3dOUU1PSUlTVUo3T01BRQ?oc=5", "source_name": "TradingView", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAAR Surgical Q1 2026: Early Signs Of A Durable Turnaround", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxNUDBUeXNMT010RGhCOXZlbnlZeS01bGpPT0RuTGdqNHY5bmpoTVdTa1MteFZsUFhnNy1mN3hWaE1lV2RqcjFEYVlLWEFUYml4b1c1emxBNWRFaTZmb2xfTXM3MjVuWDFER1JTSHRhaUVBT3lZWTlFYjdqQTgwUUhYcjc5QzJ5RzBOc1ZrMnBzOWI4R0dKZnRINkNCcmY?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-16T07:00:00+00:00", "published_display": "16 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAAR Surgical (STAA) Is Up 5.9% After Returning To Quarterly Profitability - What's Changed", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxOUU1iRUdMMHlxZ1lnTGl0cUd5WHFKZjREYjAya0lFTzUxM05yRE15eW50T2VaWU1nWlBKU3g3blZSR3NXc1NzMGJySXR2VFJUcEkyaFkwSEtEcmJSRnFEakQtT1JvWXpzVVJFYS1QMXJRUkRoQk5QWU9iRURYLUprNHFmR0JVTW5mTUVlR3BsU0o1SXM4MVRV?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAAR Surgical (NASDAQ:STAA) Beats Expectations in Strong Q1 CY2026, Stock Jumps 18.3%", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxQY0xNeXJabVY3amNPbUpRcFZTV3BsMlBmMnkybE5SSGlvRmJNVXViU0dvM0NnNWJlM0ZpcEJRMlVUUEFpRGtRZHVjdF8wT0ZIdE15X2RBVWhpd0RWaDlocGpUbzlQa1YzY1dBRlhHNnZCUmc2YmxGeXhSNkxSZ0YxQjlZU0xNNXBIM2lpTGpZdFZSWEt4Tkg0WmhpSEtTSXplTllNbV9BTm9iOTkxaFVGclYzLUI0VWd3ODFqbWF5YlZzaG5zOGkxd1dIMjFtMHVhU3VjeWdFY2R3U29GOFhZ?oc=5", "source_name": "StockStory", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Staar Surgical (STAA) Tops Q1 Earnings and Revenue Estimates", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxNODAtazJsMnRnejJEOHZRa25wTThQUmpsLVE0T0tINU5MZGhWd0N2VGpqcDlMM20xVTRJN1Z5UTg0dXVCclZyN191V01iNVNVazh0bWcyRmdaT3gtNWpUMkZDVl9xS21kTzlsQjU1MXBvdy1sZVBUdk04NmdRTWVxclpEVHIwRVhESGRBTHFTaURNWkt3RWZ3?oc=5", "source_name": "Market source", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAAR Surgical Co stock (US8577001096): Up 2.35% among top monthly gainers", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQWldleDAyTkQ0WFAzTDR4bkRlUUJDRkNuTUo2cG5fUWdJVG9EUk1udnphRFJxZDJvWF9nNHliS0JyOHp4WFh5RExsM0kyYXpGZ1p3U2dfMGRvX2swN3ZSX0tvX1hrM3QyWU5rMmJ6cjhkN2dMMzRJakFOb1lDNnBVLUxrT3BJeDJQZzQ2THd6eDVtMkV5ek5yc0JndlZMdVdlT0dfcW5MbDFVOTNkeVJLX2NXOUJ0dUJaN1BYaGRIYU5taUZ6Z0xOaw?oc=5", "source_name": "Ad-hoc-news.de", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[SCHEDULE 13G] STAAR SURGICAL CO Passive Investment Disclosure (>5%)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxOX0MtenViNV91TUVCY3Vndm9zN3dnTnJTdWY4Yk1uaXpNc2MyS0o0S3pLSEYtblUtYVlWVElYMEMzd2pmWFdoODR6VjlYeFZReEJETHJhNkRyX2g1ZW9SeTNwb0lmcWtrQ0QzNXhYc1VicWtEclVNTFh0QlRrSEdsN3ZHaEFrdktWSGRCcWdaZ0dkOFUzY0JhZ2dlTDBVT3pNWnhyaVV1NWJfWWpjZDVyS1Q3RTZHY0FPSTJsbU5tNDhTQQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-12T07:00:00+00:00", "published_display": "12 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is It Too Late To Consider STAAR Surgical (STAA) After Its Recent 1 Year Share Price Surge?", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-04-22T07:00:00+00:00", "published_display": "22 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAAR Surgical: Q1 Preliminary Revenues Justify Decision To Reject Alcon Bid (NASDAQ:STAA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMitwFBVV95cUxPQVVELWpTN3dFS082MUZFQ085SkoxeEc3a2FiTkNSTm1CdnZ1NU8yb20xdUprQUR4ODVfQ3Nfdy1xcEdrbnpXZFVlV0Z5bkRuVnpYYUxPZlZ3LUhwZ2xmY3pBYmt4bmdSN21JZ1lUQ2ZmZ201SERrWV9jR3o2eG85UWpuYVBVcURMejBqaVlrRzNuVmktRHJocHVRNFpOZmtVcV9ZVXgzd2xwamNsd21JQk0yZ2sydFU?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-04-09T07:00:00+00:00", "published_display": "09 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAAR Surgical (STAA) Is Up 8.0% After Q1 2026 Sales More Than Double - What's Changed", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgFBVV95cUxPd1NlbGc5T3dMQndfSUdSZTZBM2hGYnl2cWxVNDNINkhaVW9Lc0hmWk5yd0R4UVllcUdlTFoyQXd4QmUzN21TN1E4dFBtdlpKMzhNV3duVVVoR3dqNkdRUU5xVDhXNXFPX2hoSGZyU1Z5X3lBQ1U0SnAwWHVaQ1ZrSEdwUUNDMVNPODJrVVpoRm5EQQ?oc=5", "source_name": "Market source", "published_at": "2026-04-09T07:00:00+00:00", "published_display": "09 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "China drives STAAR Surgical sales above $90M in early 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxOVS1FZkdqQTZHTUZTY2dQSVJPcWROdGhDRkJIUWdPZ0pwSDFIVHBGZnBKUFJwbDNBMGEtVmM5S0d5cXpIanVFSFlHZk1zYXF2OTdodllXUVM3bm4zajBKWktyMHUzM3czRlR0bHpxcVBTbngtUmhxZUc2a0l1VnhXamxkY09zdWo3Yjc3X3J6aDhrYldhaGVORXFVUXIzYWFoM1hlS0hoS0JhU2QwalZOUXV3S3E3Y0lTRXEw?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-08T07:00:00+00:00", "published_display": "08 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Surging Earnings Estimates Signal Upside for Staar Surgical (STAA) Stock", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPT2Q5LU5PRzJPenExTFlheWtNeVpXeVdPSW05Ykg1ODdldVJGLWtDSU1rSEw4aGpwejdnN0YzaklMOFZMdUNaaEc2WU82RmUzYTFyUHl4T1FwUk9pRXVHbDBBM3NjbUEwQVc1c290b3gyeVROWVRxazdLSzNIMlJWckM4aDhDY05oNGM3V2V2OWNGM2E3bGlaUWZUaGVpblBnQmRTTWxoNHc?oc=5", "source_name": "Market source", "published_at": "2026-04-06T07:00:00+00:00", "published_display": "06 Apr 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why STAAR Surgical (STAA) Stock Is Trading Up Today", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQRzBvSXJzcUV0ZHFRbzF5djJUV0psUWhNUGl5Mko2aG9mTWo3cmt2aWRVYVBCWktfdHYyRTFxUFc1ZGViTnc1TnFGYWMtUWp2R1lTSERkczExeE02UlRLNVE5V1FEaVFXclduUW1mZFNObmd2UlJOeHJHMkF0akY2c01ka2tBRjU3WDctUU5PLUlkbS1TUHRDd2d0MXB2Q2Fac3N6dUxKLWM0UUhDRXJ4bA?oc=5", "source_name": "StockStory", "published_at": "2026-03-24T07:00:00+00:00", "published_display": "24 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAAR Surgical Reports Fourth Quarter and Fiscal Year 2025 Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwAFBVV95cUxOdWtCR1lLcXlJcGJuNlpPS3VUdzVFMExmcTN0UWVaRHBPNXhKa3IxOHVmd3NMYTA4SWhuWUNPNjd4bUpFcXdDdG1mOHNwbGNrby1SWDVodGJNcHdDRGNzQVVMYUhTMjRpNGdHZDQ1b21xTUl5OGxEa3FaLXNnTk5kMks1VmcxX290WU5PWTktQnhwWWNtWURteU1pLXNhTDY3TEw5MnVvVGVSUUNQQ1ZrVDV3ODZGM1c3OEx0NUJJNGM?oc=5", "source_name": "Business Wire", "published_at": "2026-03-03T08:00:00+00:00", "published_display": "03 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAAR Surgical (NASDAQ:STAA) Misses Q4 CY2025 Sales Expectations, Stock Drops 11.2%", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMXNoRHNGOVl2UW5lclZtUzhhV2tQTHRzYVVidTF3N0lSZXpaMDJESmR2TncxYTJxbnJUQ2FNckZ4NWRRUThZSUZxQzRyQXBwVzVIdURObkxXQ2xmbVhaOURONlc3QUdiZ3ZaNmFMQlBIY3o2SkhxSEdqZ05TamRjWHdIeElndw?oc=5", "source_name": "Market source", "published_at": "2026-03-03T08:00:00+00:00", "published_display": "03 Mar 2026 08:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Analysts Question STAAR Surgical Company (STAA)\u2019s Post-Merger Standalone Valuation", "summary": "", "url": "https://news.google.com/rss/articles/CBMiigFBVV95cUxQUzFhWUJLdVZqQXVaOGtnOVJqVlduN0pQVG9tNU9IVjdlOFo5TnBlaUQxblc0ZXhxc21CLXV0MG9qWDlORldUcnVPbUVpbVd1eGhlbWpEZ2RoSHFZWXBlWEhieC1hU0RtQ2g5ZDBzeDZjSzNJNGNwbFZ5YTctbV9tbGUzSUJ1MmYtOFE?oc=5", "source_name": "Market source", "published_at": "2026-01-25T08:00:00+00:00", "published_display": "25 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "STAAR Surgical terminates proposed acquisition by Alcon", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxNM2E3UDJYenlGSDlKX0lHdmRScEdXT3F1OG1xajdKd2JXSE9UZ20xX1JUWS1Gc0V2X05RT2M1MTB3MlQ5a2lnRDUtWXJmcGN4NzE5ZFYxaVdBX0FQb1A2MXZpLXFDemk0VGt4TVVGQ0xITElUdDMxUk9FaHFxVkFlOEhjZU5VTmUzLV9Vd0FtVGdqYTBnWUtnUEk4SQ?oc=5", "source_name": "Ophthalmology Times Europe", "published_at": "2026-01-06T08:00:00+00:00", "published_display": "06 Jan 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 85, "total_relevant": 48, "sentiment_summary": {"positive": 13, "negative": 2, "neutral": 33, "score": 55, "total": 48, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 79, "events": [{"event": "general", "label": "Market update", "weight": 15.0, "count": 26}, {"event": "earnings", "label": "Earnings", "weight": 5.5, "count": 10}, {"event": "analyst", "label": "Analyst action", "weight": 2.75, "count": 5}, {"event": "deals", "label": "Deals and strategy", "weight": 1.65, "count": 3}, {"event": "macro", "label": "Macro sensitivity", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 13, "negative_events": 2}, "market_context": {"has_market_context": true, "latest_close": 27.76, "latest_week": "2026-07-10", "one_week_move": -0.1, "four_week_move": -2.2, "twelve_week_move": 10.7, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 0.305126, "market_dynamics_buy_signal": false, "relative_strength": -2.720437, "fair_value_gap": -6.1, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 44.7158, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-0.1% over one week, -2.2% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 54, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 8}, {"label": "Market source", "count": 7}, {"label": "StockStory", "count": 4}, {"label": "TradingView", "count": 4}, {"label": "Stock Traders Daily", "count": 2}, {"label": "Simply Wall Street", "count": 2}, {"label": "The Globe and Mail", "count": 2}, {"label": "Investing.com Canada", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 48}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 26}, {"label": "Earnings", "count": 10}, {"label": "Analyst action", "count": 5}, {"label": "Deals and strategy", "count": 3}, {"label": "Macro sensitivity", "count": 1}, {"label": "Guidance", "count": 1}, {"label": "Regulatory and legal", "count": 1}, {"label": "Balance sheet", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "55/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "79/100 classification confidence."}, {"label": "Company focus", "value": "48", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "2", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-0.1% over one week, -2.2% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Staar Surgical's China ICL Demand Driven by Macro Affordability Pressures, Wedbush Says"}], "updated_at": "2026-07-15T23:34:34.743654+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}